HBV infection in untreated HIV-infected adults in Maputo, Mozambique
- PMID: 28759595
- PMCID: PMC5536281
- DOI: 10.1371/journal.pone.0181836
HBV infection in untreated HIV-infected adults in Maputo, Mozambique
Erratum in
-
Correction: HBV infection in untreated HIV-infected adults in Maputo, Mozambique.PLoS One. 2017 Dec 21;12(12):e0190460. doi: 10.1371/journal.pone.0190460. eCollection 2017. PLoS One. 2017. PMID: 29267379 Free PMC article.
Abstract
Background: HIV/ HBV coinfected patients are at high risk of developing chronic HBV infection, liver cirrhosis and hepatocellular carcinoma. In Mozambique, where HIV prevalence is one of the highest in the world, HIV-infected patients are scarcely characterized in terms of HBV coinfection and 3TC-resistance mutations profile.
Methods: To characterize ART-naïve HIV-infected adults, with and without HBV coinfection, a cross-sectional study was conducted between May and November 2012 in two health centers from Maputo city, Mozambique. Subjects were consecutively enrolled in the study and, then, tested for hepatitis B surface antigen (HBsAg). Moreover, CD4+ T cells count, HBV DNA in plasma, HBV genotyping and 3TC-resistance mutations profile of HBV were assessed in HIV/HBV coinfected patients.
Results: In total, 518 patients were enrolled in the study. The median age was 33 years old and 66.8% were women. The median CD4+ T cells count was 361 cells/mm3 and 47 (9.1%) were coinfected with HBV. Out of 46 coinfected patients, 24 (55.2%) had HBV DNA ≥ 20 - < 20 000 and 12 (26.1%) had HBV-DNA ≥20 000. APRI > 2.0 was reported in 4.3% of coinfected and 1.7% of monoinfected patients (p = 0.228), while FIB-4 > 3.25 was reported in 4.4% of coinfected and 1.3% of monoinfected patients (p = 0.112). Genotype A was the most frequent, identified in 25/27 (92.6%) patients, whereas genotype E was present in 2/27 (7.4%) patients. No patient had 3TC-resistance mutations.
Conclusions: This study showed that HBV coinfection was prevalent among ART-naïve HIV-infected adults in Mozambique. Overall, these data highlight the importance of screening HBV coinfection as an integrated measure of HIV routine care to improve health conditions and treatment of HIV/HBV coinfected patients.
Conflict of interest statement
Figures
Similar articles
-
High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.Antivir Ther. 2015;20(5):545-54. doi: 10.3851/IMP2942. Epub 2015 Feb 5. Antivir Ther. 2015. PMID: 25654813
-
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.Clin Infect Dis. 2012 Feb 15;54(4):548-55. doi: 10.1093/cid/cir851. Epub 2011 Dec 7. Clin Infect Dis. 2012. PMID: 22156858
-
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.Antivir Ther. 2017;22(2):97-111. doi: 10.3851/IMP3060. Epub 2016 Jun 29. Antivir Ther. 2017. PMID: 27354181
-
HBV Infection in HIV-Driven Immune Suppression.Viruses. 2019 Nov 19;11(11):1077. doi: 10.3390/v11111077. Viruses. 2019. PMID: 31752284 Free PMC article. Review.
-
Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?AIDS Rev. 2019;21(4):175-183. doi: 10.24875/AIDSRev.19000077. AIDS Rev. 2019. PMID: 31834330 Review.
Cited by
-
Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique.PLoS One. 2023 Feb 16;18(2):e0281855. doi: 10.1371/journal.pone.0281855. eCollection 2023. PLoS One. 2023. PMID: 36795797 Free PMC article.
-
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.BMC Infect Dis. 2019 Dec 2;19(1):1022. doi: 10.1186/s12879-019-4655-2. BMC Infect Dis. 2019. PMID: 31791273 Free PMC article.
-
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.Clin Microbiol Rev. 2020 Feb 26;33(2):e00046-19. doi: 10.1128/CMR.00046-19. Print 2020 Mar 18. Clin Microbiol Rev. 2020. PMID: 32102898 Free PMC article. Review.
-
Hepatitis B Virus Genotypes and Subgenotypes Circulating in Infected Residents in a Country with High Vaccination Rate.Viruses. 2024 Jun 13;16(6):954. doi: 10.3390/v16060954. Viruses. 2024. PMID: 38932246 Free PMC article.
-
Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.BMC Public Health. 2020 Jun 3;20(1):851. doi: 10.1186/s12889-020-09012-w. BMC Public Health. 2020. PMID: 32493347 Free PMC article.
References
-
- UNAIDS. AIDSInfo 2015 2015. Available from: http://aidsinfo.unaids.org/.
-
- Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7(6):402–9. doi: 10.1016/S1473-3099(07)70135-4 . - DOI - PubMed
-
- Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol. 2006;44(1 Suppl):S65–70. doi: 10.1016/j.jhep.2005.11.015 . - DOI - PubMed
-
- Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6–9. doi: 10.1016/j.jhep.2005.11.004 . - DOI - PubMed
-
- Easterbrook P, Sands A, Harmanci H. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings. Semin Liver Dis. 2012;32(2):147–57. doi: 10.1055/s-0032-1316476 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials